EPISODE · May 13, 2026 · 2 MIN
Aytu BioPharma's EXXUA Antidepressant: Strong Start, Promising Future
from The Daily News Now! Business
Aytu BioPharmas fiscal Q3 2026 results show promising start for new antidepressant EXXUA, with $2.4M in sales from over 1300 prescriptions by 450+ doctors. Despite net loss of $5.6M, EXXUAs momentum is evident with 51% increase in units shipped from March to April. Positive doctor and patient feedback, along with smooth reimbursements, position EXXUA as a major player in MDD treatment. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/8fed7585f326cbc6
NOW PLAYING
Aytu BioPharma's EXXUA Antidepressant: Strong Start, Promising Future
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m